MD. General Surgeon, Department of General Surgery, Yenimahalle Training and Research Hospital, Yildirim Beyazıt University, Ankara, Turkey.
MD. Psychiatrist, Private Emre Kizil Psychiatry Clinic, Cankaya, Ankara, Turkey.
Sao Paulo Med J. 2020 Jul-Aug;138(4):282-286. doi: 10.1590/1516-3180.2019.0527.R1.16042020.
Very few data are available for evaluating health-related quality of life among people with irritable bowel syndrome (IBS) and even fewer data are available in relation to anxiety and depression status among these patients.
To evaluate the quality of life, anxiety and depression status of patients with IBS.
Observational cohort study conducted in a tertiary-care university hospital.
Patients who had recently been diagnosed with IBS and who had been followed up for IBS-specific treatment for at least three months were included. A quality of life (QoL) survey, the Beck Anxiety Index (BAI) and the Hamilton Depression Index (HAM-D) were applied to the patients.
In total, 274 patients with IBS were included in the study cohort. These patients presented very high baseline scores for anxiety and depression, and very poor QoL results.
Our study showed that IBS had a very high impact on these patients, regarding their anxiety and depression levels, alongside very poor results relating to quality of life.
评估肠易激综合征(IBS)患者的健康相关生活质量的数据非常有限,而这些患者的焦虑和抑郁状况的数据则更为有限。
评估 IBS 患者的生活质量、焦虑和抑郁状况。
在一家三级保健大学医院进行的观察性队列研究。
纳入最近被诊断为 IBS 并接受至少三个月 IBS 特异性治疗的患者。对患者进行生活质量(QoL)调查、贝克焦虑指数(BAI)和汉密尔顿抑郁指数(HAM-D)评估。
共有 274 名 IBS 患者纳入研究队列。这些患者的焦虑和抑郁基线评分非常高,生活质量结果非常差。
我们的研究表明,IBS 对这些患者的焦虑和抑郁水平有很大的影响,同时生活质量也很差。